We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Ross Carly has been assisting clients through the H1B Visa process since 2017.

As of 2022, Ross Carly has succesfully submitted and recieved certification for 421 cases.

Ross Carly is located in Toronto, , and has represented 14 employers for the H1B Visa Process

434
Cases Handled
421
Cases Certified
97.00%
Approval

Cases Handled by Ross Carly

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-18129-584929 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2018
I-200-18121-983436 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2018
I-200-18096-019431 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2018
I-200-18087-209120 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2018
I-200-18081-306844 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2018
I-200-18072-668701 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2018
I-200-18068-798034 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2018
I-200-18064-536892 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2018
I-200-19108-962062 CERTIFIED Engineers All Other Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2019
I-200-19092-574302 CERTIFIED Engineers All Other Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2019